Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene

Cancer Research

Volumn 62, Issue 12, 2002, Pages 3387-3394

  Comerford, Katrina M ^a   Wallace, Timothy J ^a   Karhausen, Jörn ^a   Louis, Nancy A ^a   Montalto, Michael C ^a   Colgan, Sean P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DIGOXIN; DOXORUBICIN; GLYCOPROTEIN P; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; RHODAMINE 123; VERAPAMIL;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL STRAIN CACO 2; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; MICROVASCULATURE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CACO-2 CELLS; CELL HYPOXIA; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA-BINDING PROTEINS; ENDOTHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NUCLEAR PROTEINS; P-GLYCOPROTEIN; TRANSCRIPTION FACTORS;

EID: 0037096732     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Multidrug resistance-associated protein subfamily transporters and drug resistance
2. The P-glycoprotein multidrug transporter
3. MDR1 gene expression in solid tumours
4. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y
5. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-κB/p65 and c-Fos transcription factors and their interaction with the CAAT region
6. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
7. 2 homeostasis
8. Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1
9. 2-dependent degradation domain via the ubiquitinproteasome pathway
10. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
11. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
12. Epithelial exposure to hypoxia modulates neutrophil transepithelial migration
13. +-dependent glucose cotransporter (SGLT1): Maintenance of surface expression and global transport function with selective perturbation of transport kinetics and polarized expression
14. Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial TNFα
15. The plasma membrane polarity of human biliary epithelial cells: In situ immunohistochemical analysis and functional implications
16. 2B receptor activation
17. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics
18. Hypoxia enhances stimulus-dependent induction of E-selectin on aortic endothelial cells
19. Phosphorylation dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia
20. Expression monitoring by hybridization to high-density oligonucleotide arrays
21. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis
22. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue
23. Multidrug resistance proteins and other drug transport-related resistance to natural product agents
24. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay
25. CD 47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia
26. 3
27. Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence
28. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene
29. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins
30. Autocrine regulation of intestinal epithelial permeability induced by hypoxia: Role for basolateral release of tumor necrosis factor-α (TNF-α)
31. P-Glycoprotein system as a determinant of drug interactions: The case of digoxin-verapamil
32. Monoclonal antibodies specific for P-glycoprotein
33. Cell culture as spheroids: An approach to multicellular resistance
34. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide
35. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity
36. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure
37. Exploiting the hypoxic cancer cell: Mechanisms and therapeutic strategies
38. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
39. Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells
40. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines
41. Hypoxia-induced drug resistance: Comparison to P-glycoprotein associated drug resistance
42. The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast-cancer cells in vitro
43. Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat shock transcription factor 1 (HSF1)
44. Regulation of the MDR1 promoter by cyclic AMP dependent protein kinase and transcription factor Sp1
45. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells
46. Involvement of the transcription factor NF-IL6 in phorbol ester induction of P-glycoprotein in U937 cells
47. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1
48. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene
49. Sp1 and egr-1 have opposing effects on the regulation of the rat Pgp2/mdr1b gene
50. Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line KBV200
51. The physiological function of drug-transporting P-glycoproteins
52. HIF-1α is required for solid tumor formation and embryonic vascularization
53. Multidrug resistance: Clinical relevance in solid tumours and strategies for circumvention
54. Targeting gene expression to hypoxic tumor cells
55. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
56. A conserved family of prolyl-4-hydroxylases that modify HIF
57. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation